AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vribose M 0.2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (0.2mg)

Overview Vribose M 0.2 Tablet SR

Diabex Duo 0.2mg Extended-Release Tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and visual impairment, potentially lowering the risk of cardiovascular events. Diabex Duo 0.2mg ER may be used independently or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a prescribed diet and consistent physical activity. Dosage is personalized based on your health status, glucose readings, and existing medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinue only under medical guidance. Effective blood sugar control contributes to the prevention of future complications. Maintaining the recommended diet and exercise program is vital for overall diabetes management; lifestyle significantly impacts control. Common adverse effects may include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all patients. Prior to initiating treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Interactions with other medications are possible; disclose all current medications for safety assessment. Alcohol should be limited due to its hypoglycemic effects. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout your treatment.

Primary Ingredients of Vribose M 0.2 Tablet SR

No text provided. Please provide the text you would like me to rephrase.

Uses of Vribose M 0.2 Tablet SR

Managing type 2 diabetes

Major Benefits of Vribose M 0.2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vribose M 0.2 Tablet SR with a meal.

Common Side effects of Vribose M 0.2 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vribose M 0.2 Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vribose M 0.2 Tablet SR with a meal.

How Vribose M 0.2 Tablet SR works:

The extended-release tablet, Vribose M 0.2 SR, contains a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vribose M 0.2 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vribose M 0.2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Vribose M 0.2mg tablet should likely be avoided while breastfeeding. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vribose M 0.2 SR tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Vribose M 0.2 Tablet SR is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Vribose M 0.2 Tablet SR :

Should you forget to take a Vribose M 0.2 Tablet SR, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vribose M 0.2 Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Vribose M 0.2 Tablet SR

Vribose M 0.2 Tablet SR rarely causes hypoglycemia by itself, but low blood sugar can result from inadequate caloric intake while using it. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vribose M 0.2 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always seek medical advice before taking additional medication.
Vribose M 0.2 Tablet SR is contraindicated in patients allergic to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Vribose M 0.2 SR tablets combine metformin (a biguanide) and vildagliptin, both anti-diabetic medications. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18 years old.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential, though rare, side effect of Vribose M 0.2 Tablet SR. This condition results from excessive lactic acid in the bloodstream. It's particularly important to avoid use in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Vribose M 0.2 Tablet SR and seek immediate medical attention.
Prolonged use of Vribose M 0.2 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vribose M 0.2 Tablet SR as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Vribose M 0.2 Tablet SR
66
MRP 76
13% off